Search research articles
Contact Us
Filters
Showing results (201-210 of 504) with videos related to
Page
of 51
Sort By:
Expert Opinion on Drug Safety
|
July 23, 2020
A real-world disproportionality analysis of FDA Adverse Event Reporting System (FAERS) events for baricitinib
Ling Peng, Kui Xiao, Silvia Ottaviani, et al.
Molecular and Cellular Biology
|
August 7, 2013
Emerging roles of competing endogenous RNAs in cancer: insights from the regulation of PTEN
Alexander de Giorgio, Jonathan Krell, Victoria Harding, et al.
Journal of Molecular Endocrinology
|
July 27, 2014
Noncoding RNAs and the control of hormonal signaling via nuclear receptor regulation
Silvia Ottaviani, Alexander de Giorgio, Victoria Harding, et al.
Pharmacogenomics
|
April 21, 2012
Highlights from the latest articles in breast cancer pharmacogenomics
Jonathan Krell, Adam E Frampton, Ingolf Cascorbi, et al.
Expert Review of Anticancer Therapy
|
May 19, 2012
Retinoblastoma protein determines aggressiveness in triple-negative breast cancer
Jimmy Jacob, Adam E Frampton, Leandro Castellano, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease
|
January 1, 2019
The LMTK-family of kinases: Emerging important players in cell physiology and pathogenesis
Franz Wendler, Teodora-Maria Purice, Thomas Simon, et al.
Future Oncology (London, England)
|
December 22, 2009
Clinical utility of circulating tumor cell measurement in the diagnosis of indeterminate lesions of the pancreas
Satvinder Mudan, Alexandros Giakoustidis, Andrew V Thillainayagam, et al.
Oncogene
|
April 3, 2026
The role of Rho-associated coiled-coil kinases (ROCK) in cancer
Laura Zafrany, Rui Wu, Amy Melsaether, et al.
Pharmacogenomics
|
April 21, 2012
miRNAs in breast cancer: ready for real time?
Jonathan Krell, Adam E Frampton, Jimmy Jacob, et al.
AIDS (London, England)
|
June 27, 2008
Fanconi syndrome and lactic acidosis associated with stavudine and lamivudine therapy
Mark Nelson, Alex Azwa, Ahmed Sokwala, et al.
Page
of 51
Search research articles
Search
Showing results (201-210 of 504) with videos related to
Sort By:
Page
of 51
Expert Opinion on Drug Safety
|
July 23, 2020
A real-world disproportionality analysis of FDA Adverse Event Reporting System (FAERS) events for baricitinib
Ling Peng, Kui Xiao, Silvia Ottaviani, et al.
Molecular and Cellular Biology
|
August 7, 2013
Emerging roles of competing endogenous RNAs in cancer: insights from the regulation of PTEN
Alexander de Giorgio, Jonathan Krell, Victoria Harding, et al.
Journal of Molecular Endocrinology
|
July 27, 2014
Noncoding RNAs and the control of hormonal signaling via nuclear receptor regulation
Silvia Ottaviani, Alexander de Giorgio, Victoria Harding, et al.
Pharmacogenomics
|
April 21, 2012
Highlights from the latest articles in breast cancer pharmacogenomics
Jonathan Krell, Adam E Frampton, Ingolf Cascorbi, et al.
Expert Review of Anticancer Therapy
|
May 19, 2012
Retinoblastoma protein determines aggressiveness in triple-negative breast cancer
Jimmy Jacob, Adam E Frampton, Leandro Castellano, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease
|
January 1, 2019
The LMTK-family of kinases: Emerging important players in cell physiology and pathogenesis
Franz Wendler, Teodora-Maria Purice, Thomas Simon, et al.
Future Oncology (London, England)
|
December 22, 2009
Clinical utility of circulating tumor cell measurement in the diagnosis of indeterminate lesions of the pancreas
Satvinder Mudan, Alexandros Giakoustidis, Andrew V Thillainayagam, et al.
Oncogene
|
April 3, 2026
The role of Rho-associated coiled-coil kinases (ROCK) in cancer
Laura Zafrany, Rui Wu, Amy Melsaether, et al.
Pharmacogenomics
|
April 21, 2012
miRNAs in breast cancer: ready for real time?
Jonathan Krell, Adam E Frampton, Jimmy Jacob, et al.
AIDS (London, England)
|
June 27, 2008
Fanconi syndrome and lactic acidosis associated with stavudine and lamivudine therapy
Mark Nelson, Alex Azwa, Ahmed Sokwala, et al.
Page
of 51